RecruitingNCT04844944

The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases

The Helios Heart Registry: A Standardized Registry for Capturing Clinical and Patient-reported Outcomes in Patients With Specific Cardiac Diseases: Application of the ICHOM Standard in Clinical Practice


Sponsor

Helios Health Institute GmbH

Enrollment

24,000 participants

Start Date

Mar 30, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Investigator-initiated, prospective, non-randomized, open label, non-interventional multicenter registry to evaluate current treatment of three major cardiovascular disease entities in clinical practice using a standardized variable-set of relevant covariates and outcome measures.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Age of 18 years or older
  • Inpatient Treatment
  • Present diagnosis of at least one of the three cardiovascular disease entities of interest according to the current guidelines of the European Society of Cardiology (ESC): HF, CAD, AF

Exclusion Criteria3

  • Inability to provide informed consent
  • Initial presentation (index hospitalization) in cardiogenic shock or other kinds of shock
  • Patient after heart transplantation or patient with present ventricular assist device (VAD)

Locations(10)

Helios Klinikum Berlin-Buch

Berlin, Germany

Helios Klinikum Erfurt

Erfurt, Germany

Helios Klinikum Gifhorn

Gifhorn, Germany

Helios Klinikum Hildesheim

Hildesheim, Germany

Heart Center Leipzig at University of Leipzig

Leipzig, Germany

Helios Vogtlandklinikum Plauen

Plauen, Germany

Helios Klinikum Schwerin

Schwerin, Germany

Helios Klinikum Siegburg

Siegburg, Germany

Helios Dr. Horst Schmidt Kliniken Wiesbaden

Wiesbaden, Germany

Helios Universitätsklinikum Wuppertal

Wuppertal, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04844944


Related Trials